AusperBio Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $73,000,000
Company Info
- Company Description
- AusperBio Therapeutics is a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic hepatitis B (CHB).
- Market
- Chronic Hepatitis B Treatment
- Location
- San Francisco, California, USA
- Coinvestors
- HanKang Capital, Sherpa Capital, CDH Investments, Qiming Venture Partners, InnoPinnacle Fund, YuanBio Venture Capital